Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma

The objective of this retrospective analysis was to compare outcomes of patients with diffuse large B-cell lymphoma (DLBCL) who received either a matched sibling (sib) or an unrelated donor (URD) allogeneic hematopoietic cell transplantation (allo-HCT). Long-term outcome of 172 DLBCL patients receiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Avivi, Irit (Author) , Canals, C. (Author) , Vernant, J.-P. (Author) , Wulf, G. (Author) , Nagler, A. (Author) , Hermine, O. (Author) , Petersen, E. (Author) , Yakoub-Agha, I. (Author) , Craddock, C. (Author) , Schattenberg, A. (Author) , Niederwieser, D. (Author) , Thomson, K. (Author) , Blaise, D. (Author) , Attal, M. (Author) , Pfreundschuh, M. (Author) , Passweg, J. (Author) , Russell, N. (Author) , Dreger, Peter (Author) , Sureda, A. (Author)
Format: Article (Journal)
Language:English
Published: 10 February 2014
In: Bone marrow transplantation
Year: 2014, Volume: 49, Issue: 5, Pages: 671-678
ISSN:1476-5365
DOI:10.1038/bmt.2014.4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bmt.2014.4
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bmt20144
Get full text
Author Notes:I Avivi, C Canals, J-P Vernant, G Wulf, A Nagler, O Hermine, E Petersen, I Yakoub-Agha, C Craddock, A Schattenberg, D Niederwieser, K Thomson, D Blaise, M Attal, M Pfreundschuh, J Passweg, N Russell, P Dreger, A Sureda on behalf of the EBMT Lymphoma Working Party

MARC

LEADER 00000caa a2200000 c 4500
001 1728806097
003 DE-627
005 20230426091334.0
007 cr uuu---uuuuu
008 200903s2014 xx |||||o 00| ||eng c
024 7 |a 10.1038/bmt.2014.4  |2 doi 
035 |a (DE-627)1728806097 
035 |a (DE-599)KXP1728806097 
035 |a (OCoLC)1341358539 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Avivi, Irit  |e VerfasserIn  |0 (DE-588)1072785331  |0 (DE-627)828235546  |0 (DE-576)43424256X  |4 aut 
245 1 0 |a Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma  |c I Avivi, C Canals, J-P Vernant, G Wulf, A Nagler, O Hermine, E Petersen, I Yakoub-Agha, C Craddock, A Schattenberg, D Niederwieser, K Thomson, D Blaise, M Attal, M Pfreundschuh, J Passweg, N Russell, P Dreger, A Sureda on behalf of the EBMT Lymphoma Working Party 
264 1 |c 10 February 2014 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.09.2020 
520 |a The objective of this retrospective analysis was to compare outcomes of patients with diffuse large B-cell lymphoma (DLBCL) who received either a matched sibling (sib) or an unrelated donor (URD) allogeneic hematopoietic cell transplantation (allo-HCT). Long-term outcome of 172 DLBCL patients receiving URD-HCT between 2000 and 2007 and reported to the European Group for Blood and Marrow Transplantation, was compared with that of 301 subjects, allografted from sib-HCT. With a median follow-up of 45 months, 3-year PFS approached 35% for both groups; overall survival (OS) was 42% for sib-HCT versus 37% for URD (NS). Multivariate analyses confirmed that donor type was not associated with differences in non-relapse mortality (NRM), relapse rate (RR), PFS or OS. Poor performance status (PS) and refractory disease adversely affected PFS and OS. Prior auto-SCT and multiple previous therapies predicted for shorter PFS. NRM was adversely affected by older age (⩾50 years), poor PS and refractory disease, and RR by time from diagnosis to allo-HCT of <36 months, prior auto-SCT, refractory disease, poor PS and in vivo T-cell depletion with alemtuzumab. This large study shows for the first time that URD-HCT is not inferior to sib-HCT, providing a reasonable therapeutic approach for DLBCL patients, having no HLA-identical sibling available. 
700 1 |a Canals, C.  |e VerfasserIn  |4 aut 
700 1 |a Vernant, J.-P.  |e VerfasserIn  |4 aut 
700 1 |a Wulf, G.  |e VerfasserIn  |4 aut 
700 1 |a Nagler, A.  |e VerfasserIn  |4 aut 
700 1 |a Hermine, O.  |e VerfasserIn  |4 aut 
700 1 |a Petersen, E.  |e VerfasserIn  |4 aut 
700 1 |a Yakoub-Agha, I.  |e VerfasserIn  |4 aut 
700 1 |a Craddock, C.  |e VerfasserIn  |4 aut 
700 1 |a Schattenberg, A.  |e VerfasserIn  |4 aut 
700 1 |a Niederwieser, D.  |e VerfasserIn  |4 aut 
700 1 |a Thomson, K.  |e VerfasserIn  |4 aut 
700 1 |a Blaise, D.  |e VerfasserIn  |4 aut 
700 1 |a Attal, M.  |e VerfasserIn  |4 aut 
700 1 |a Pfreundschuh, M.  |e VerfasserIn  |4 aut 
700 1 |a Passweg, J.  |e VerfasserIn  |4 aut 
700 1 |a Russell, N.  |e VerfasserIn  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Sureda, A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 49(2014), 5, Seite 671-678  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma 
773 1 8 |g volume:49  |g year:2014  |g number:5  |g pages:671-678  |g extent:8  |a Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma 
856 4 0 |u https://doi.org/10.1038/bmt.2014.4  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bmt20144  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200903 
993 |a Article 
994 |a 2014 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 18 
999 |a KXP-PPN1728806097  |e 3746274109 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma","title_sort":"Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma"}],"name":{"displayForm":["I Avivi, C Canals, J-P Vernant, G Wulf, A Nagler, O Hermine, E Petersen, I Yakoub-Agha, C Craddock, A Schattenberg, D Niederwieser, K Thomson, D Blaise, M Attal, M Pfreundschuh, J Passweg, N Russell, P Dreger, A Sureda on behalf of the EBMT Lymphoma Working Party"]},"person":[{"role":"aut","given":"Irit","display":"Avivi, Irit","family":"Avivi"},{"display":"Canals, C.","role":"aut","given":"C.","family":"Canals"},{"family":"Vernant","role":"aut","given":"J.-P.","display":"Vernant, J.-P."},{"display":"Wulf, G.","given":"G.","role":"aut","family":"Wulf"},{"family":"Nagler","display":"Nagler, A.","given":"A.","role":"aut"},{"role":"aut","given":"O.","display":"Hermine, O.","family":"Hermine"},{"display":"Petersen, E.","given":"E.","role":"aut","family":"Petersen"},{"family":"Yakoub-Agha","given":"I.","role":"aut","display":"Yakoub-Agha, I."},{"family":"Craddock","display":"Craddock, C.","role":"aut","given":"C."},{"family":"Schattenberg","role":"aut","given":"A.","display":"Schattenberg, A."},{"given":"D.","role":"aut","display":"Niederwieser, D.","family":"Niederwieser"},{"display":"Thomson, K.","role":"aut","given":"K.","family":"Thomson"},{"family":"Blaise","display":"Blaise, D.","role":"aut","given":"D."},{"family":"Attal","display":"Attal, M.","given":"M.","role":"aut"},{"display":"Pfreundschuh, M.","role":"aut","given":"M.","family":"Pfreundschuh"},{"given":"J.","role":"aut","display":"Passweg, J.","family":"Passweg"},{"display":"Russell, N.","given":"N.","role":"aut","family":"Russell"},{"given":"Peter","role":"aut","display":"Dreger, Peter","family":"Dreger"},{"given":"A.","role":"aut","display":"Sureda, A.","family":"Sureda"}],"recId":"1728806097","origin":[{"dateIssuedDisp":"10 February 2014","dateIssuedKey":"2014"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 03.09.2020"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320433366","origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke ; London"}],"note":["Gesehen am 17.01.25"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2004030-1"],"issn":["1476-5365"],"eki":["320433366"]},"disp":"Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphomaBone marrow transplantation","pubHistory":["Nachgewiesen 19.1997 -"],"part":{"volume":"49","text":"49(2014), 5, Seite 671-678","year":"2014","extent":"8","pages":"671-678","issue":"5"},"language":["eng"],"title":[{"title_sort":"Bone marrow transplantation","title":"Bone marrow transplantation"}]}],"id":{"doi":["10.1038/bmt.2014.4"],"eki":["1728806097"]},"physDesc":[{"extent":"8 S."}]} 
SRT |a AVIVIIRITCMATCHEDUNR1020